Compare Novavax Inc (NVAX) vs Snap Inc (SNAP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Snap Inc — how do they compare? Novavax Inc trades at $8.06 (market cap $1.30B), while Snap Inc trades at $4.57 (market cap $7.67B). The key difference: Snap Inc is far larger — about 5.9× Novavax Inc's market cap, and Novavax Inc is trading nearer its 52-week high, Snap Inc nearer its low. Which is the better fit depends on your goals.
| NVAX | SNAP | |
|---|---|---|
Market Cap | $1.30B | $7.67B |
Sector | Health | Media |
52-Week High | $11.19 | $10.35 |
52-Week Low | $6.22 | $3.93 |
Enterprise Value | $800.50M | $9.05B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Snap Inc
Snap, which refers to itself as a camera company, has one of the most popular social networking apps, Snapchat, in developed regions such as North America and Europe. The firm has approximately 158 million daily active users. Snap generates nearly all of its revenue from advertising with 88% coming from the U.S. The firm is headquartered in Venice, California.
Read more on SNAP →
